Effect of dual task as rehabilitation therapy in Parkinson’s disease in the UPDRS III
Objective: To determine the effect of the dual task used as Rehabilitation therapy in the UPDRS III of patients with Parkinson's disease. Background: Parkinson's disease…Combined catechol-O-methyl-transferase inhibition and intrajejunal Levodopa infusion: A real-life single-centre experience
Objective: To explore if catechol-O-methyl-transferase inhibition (COMT-I) can prolong the efficacy of daytime intrajejunal Levodopa infusion (IJLI) in Parkinson’s disease (PD) along with a reduction…A novel mGlu4 PAM alleviates motor symptoms in primate models of PD and of LID
Objective: Objective was to assess the therapeutic potential of our novel mGlu4 positive allosteric modulator (PAM), foliglurax, as an anti-parkinsonian treatment in gold-standard primate models.…Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: NMSS analysis from the BIPARK-I double-blind experience
Objective: To evaluate the impact on non-motor symptoms in levodopa-treated Parkinson’s Disease (PD) patients with ‘early’ motor fluctuations. Background: Opicapone (OPC), a new once-daily COMT…Epidemiological and clinical profile of Parkinson’s disease in Douala
Objective: The aim of our study was to determine the hospital prevalence and describe the epidemiological and clinical profile of Parkinson’s disease in Douala Background:…Surface mechanised nano-formulation of naringenin as adenosine A2A receptor antagonist against in Neurological associated problem of Parkinson
Objective: In the current experimental study, we intended to develop Surface mechanized nano-formulation of naringenin (NG) as potent A(2A)AR antagonists against parkinson’s disease. Background: One…What makes a successful Phase 2 study: An evaluation of Parkinson’s neuroprotective trial design over the last 5 years
Objective: To evaluate variation in Phase 2 and 3 Parkinson’s disease (PD) neuroprotective trial designs and identify key trial design features in Phase 2 studies…Dual task in the daily life of patients with Parkinson’s disease
Objective: Determine which of the types of motor or cognitive tasks interfere most severely in the dual task in the daily life of patients with…Efficacy and security starting safinamide treatment with 100 mg/day in PD
Objective: Evaluating the efficacy and security starting safinamide treatment with 100 mg/day in PD Background: Dopaminergic treatment has been useful in PD. Other neurotransmission mechanisms…Impact on the Quality of Life (CV) of people with Parkinson’s disease participating in community workshops of the public health system of Coquimbo, Chile
Objective: To show the Impact in the CV of the People with Parkinson's Disease through the permanent assistance to the multidisciplinary community workshops of their…
- « Previous Page
- 1
- …
- 144
- 145
- 146
- 147
- 148
- …
- 177
- Next Page »